Immunology of Infectious Disease News Volume 12.03 | Jan 31 2024

    0
    7







    2024-01-31 | IIDN 12.04


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 12.04 – 31 January, 2024
    TOP STORY

    Virological Characteristics of the SARS-CoV-2 BA.2.86 Variant

    Scientists examined the virological characteristics of the BA.2.86 variant. Their epidemic dynamics modeling suggested that the relative reproduction number of BA.2.86 was significantly higher than that of EG.5.1.
    [Cell Host & Microbe]

    Full ArticleGraphical Abstract
    Who does immunology research in the Bolivian Andes? He does. Read Jason Young's story.
    PUBLICATIONSRanked by the impact factor of the journal

    Identification of a Highly Conserved Neutralizing Epitope within the RBD Region of Diverse SARS-CoV-2 Variants

    Investigators identified a highly conserved neutralizing epitope targeted by a broad-spectrum neutralizing antibody BA7535, which demonstrated high neutralization potency against previous variants, such as Alpha, Beta, Gamma, Delta, and Omicron BA.1-BA.5, and more recently emerged Omicron subvariants.
    [Nature Communications]

    Full Article

    Herpes Zoster After the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Actively Treated Cancer Patients: A Prospective Study

    Researchers performed a prospective analysis of the Vax-On-Third-Profile study to investigate the incidence of HZ after the third dose of mRNA-BNT162b2 and its correlation with immune responses.
    [Clinical And Experimental Medicine]

    Full Article

    Cycle Threshold of SARS-CoV-2 RT-PCR as a Driver of Retesting

    Scientists investigated patterns of retesting in association with initial cycle threshold (Ct)-values. They performed a retrospective analysis of RT-PCR results for patients from whom ≥ 2 samples were collected within 14 days, the first of which had to be positive.
    [Scientific Reports]

    Full Article

    Phase II Prefusion Non-Stabilized COVID-19 mRNA Vaccine Randomized Study

    ChulaCov19 mRNA vaccine demonstrated promising Phase I results. Healthy adults aged 18–59 years were double-blind randomized 4:1 to receive two intramuscular doses of ChulaCov19 50 µg or placebo.
    [Scientific Reports]

    Full Article

    Real-Time Dissection of the Exosome Pathway for Influenza Virus Infection

    Scientists developed a dual-color exosome labeling strategy that simultaneously labels the external and internal structures of exosomes with quantum dots. Their finding revealed that vExos contains the complete influenza A virus genome and viral ribonucleoprotein complexes proteins but lacks viral envelope proteins.
    [ACS Nano]

    AbstractGraphical Abstract

    BHLHE40 Drives Protective Polyfunctional CD4 T Cell Differentiation in the Female Reproductive Tract Against Chlamydia

    Researchers investigated the role of Bhlhe40 in protective T cell responses to the intracellular bacterium Chlamydia in the female reproductive tract.
    [PLOS Pathogens]

    Full Article

    Influenza Virus Infection Enhances Tumor-Specific CD8+ T Cell Immunity, Facilitating Tumor Control

    In several preclinical mouse models of cancer, including melanoma and colorectal cancer, investigators observed that influenza A virus infection in the lung significantly decreased the tumor burden.
    [PLOS Pathogens]

    Full Article

    Using Immune Clusters for Classifying Mycobacterium Tuberculosis Infection

    Immune indicators involved in innate, humoral, and cellular immune cells, as well as antigen-specific cells were simultaneously assessed in patients with active tuberculosis and latent tuberculosis infection.
    [International Immunopharmacology]

    Full Article
    Stop wasting time. Switch to a more efficient way to isolate cells. Learn more.
    REVIEWS

    Pneumocystis jirovecii Pneumonia in People Living with HIV: A Review

    The authors consolidate the scientific body of literature on the diagnosis and management of Pneumocystis jirovecii pneumonia in people with HIV, as well as identify areas in need of more study and thoughtfully designed clinical trials.
    [Clinical Microbiology Reviews]

    Abstract
    INDUSTRY AND POLICY NEWS

    Measles Surge Causes Alarm: What Scientists Think

    On 19 January, the UK Health and Security Agency, the public-health authority, declared a national incident over rising cases of measles. The agency has logged more than 200 cases since 1 October 2023.
    [Nature]

    Press Release

    Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-Bâ„¢

    Longeveron Inc. announced it received a notice of patent allowance from the United States Patent and Trademark Office for Medicinal Signaling Cells. The allowance impacts patients with Aging-related Frailty receiving vaccines for conditions such as COVID and the flu.
    [Longeveron Inc]

    Press Release
    FEATURED EVENT

    14th Lorne Infection & Immunity 2024

    February 14 – 16, 2024
    Lorne, Australia

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Infectious Diseases

    King’s College London – London, England, United Kingdom

    Research Associate – Microbiomics and Metabonomics

    Imperial College London – London, England, United Kingdom

    Experimental Scientist – Avian Infectious Diseases

    CSIRO – Canberra, Australia

    Postdoctoral Researcher – Human Endogenous Retrovirus Envelope and SARS-CoV-2

    Instituto Aragon̩s de Ciencias de la Salud РZaragoza, Spain

    Researcher – Infectious Diseases

    Uppsala University – Uppsala, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2